Clinical Trials Directory

Trials / Unknown

UnknownNCT00860184

SmartRisk Stroke Prediction by MRI of Carotid Disease

Assessment of MRI-based Prediction of Stroke and Other Cerebrovascular Symptoms Arising From Carotid Atherosclerotic Disease in Asymptomatic Individuals

Status
Unknown
Phase
Study type
Observational
Enrollment
300 (estimated)
Sponsor
VPDiagnostics · Industry
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

Atherosclerotic plaque at the carotid artery bifurcation is a major source of stroke. The purpose of this investigation is to determine the ability of the SmartRisk software module to predict stroke or stroke-related events due to carotid plaque within a high-risk population. The SmartRisk software module operates on magnetic resonance images (MRI) of the carotid artery wall.

Detailed description

Carotid artery disease (atherosclerosis) is a major cause of stroke that can be treated with carotid endarterectomy surgery (CEA) or stenting. Subjects with moderate, asymptomatic stenosis (50-79% narrowing) typically do not undergo intervention because the procedural risks outweigh the benefits. However, some of these individuals will have vulnerable plaque that places them at high risk of stroke, but current diagnostic techniques for vulnerable plaque are lacking. Recently, VPDiagnostics developed a new module - SmartRisk - that stratifies risk of stroke for stenotic (50-79% blockage) atherosclerotic plaque. The SmartRisk module uses MRI data to compute a risk assessment from a specific atherosclerotic plaque. A continuous risk value is generated and patients with risk values above a prespecified threshold are at elevated risk for cerebrovascular events arising from carotid artery disease. The purpose of this trial is to determine whether the SmartRisk module is effective at stratifying risk of a carotid-related cerebrovascular event in subjects with asymptomatic 50-79% carotid stenosis.

Conditions

Timeline

Start date
2009-11-01
Primary completion
2012-08-01
Completion
2012-08-01
First posted
2009-03-12
Last updated
2011-04-14

Locations

15 sites across 1 country: United States

Source: ClinicalTrials.gov record NCT00860184. Inclusion in this directory is not an endorsement.